Type 2 diabetes trials in Germany

In Germany 60 Also abroad 1200

60 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
Where
Berlin, Bochum, Bünde, Dresden, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Offenbach Am Main, Schwerin
Age
18 years and over
People
420 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524616-11-00 · EU 2025-524616-11-00
No phaseTaking people
LIfestyle MEtabotype Study A
Where
Potsdam
Age
40 years to 75 years
People
300
Run by
German Institute of Human Nutrition
See details and how to joinNCT07868601
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Where
Amberg, Bad Oeynhausen, Berlin, Bochum, Bünde, Essen, Hof, Mannheim
Age
18 years to 75 years
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00
Phase 1Taking people
A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
Where
Neuss
Age
18 years to 64 years
People
124
Run by
Eli Lilly and Company
See details and how to joinNCT06945406 · EU 2024-519151-28-00
No phaseTaking people
Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes
Where
Nuthetal
Age
18 years to 75 years
People
30
Run by
German Institute of Human Nutrition
See details and how to joinNCT07171281
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Dresden, Duisburg, Essen, Hamburg, Köln, Leipzig, Lingen, Mainz, Mannheim, Oldenburg in Holstein, Wangen im Allgäu
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
Phase 1Taking people
An Open-Label, Controlled, Multiple-Dose Phase I Clinical Trial Evaluating the Steady-State Pharmacokinetics, Pharmacodynamics and Safety of SHR-3167 in Subjects With Type 2 Diabetes
Where
Neuss
Age
18 years and over
People
35
Run by
Jiangsu Hengrui Pharmaceuticals Co. Ltd.
See details and how to join2026-525932-40-00 · EU 2026-525932-40-00
Phase 3Taking people
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Where
Berlin, Essen, Hanover
Age
18 years and over
People
1,560 worldwide
Run by
Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743450
Phase 1/2Taking people
A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D
Where
Neuss
Age
18 years to 75 years
People
188
Run by
Gubra A/S
See details and how to joinNCT07702890 · EU 2025-524921-42-00
Phase 3Taking people
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
Where
Bad Oeynhausen, Bochum, Cologne, Dresden, Falkensee, Gera, Hamburg, Köln, Leipzig, Luebeck, Mainz, Mannheim, Muenster, München, Nürnberg, Obertshausen, Oldenburg in Holstein, Stuttgart, Ulm, Wangen im Allgäu, Wuerzburg
Age
18 years and over
People
1,010 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524688-19-00 · EU 2025-524688-19-00
Phase 3Not yet taking people in Germany
Study of a DPP 4 inhibitor and an SGLT2 inhibitor used together compared with each treatment alone in adults with type 2 diabetes treated with metformin.
Where
Berlin, Offenbach Am Main
Age
18 years and over
People
760 worldwide
Run by
Tecnimede-Sociedade Tecnico-Medicinal S.A.
See details and how to join2025-524606-15-00 · EU 2025-524606-15-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Bad Oeynhausen, Berlin, Chemnitz, Duisburg, Erlangen, Frankfurt am Main, Hamburg, Heilbronn, Hohenmölsen, Ludwigshafen, Münster, Nittendorf, Obertshausen, Pirna, St Ingbert, Stuttgart
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
Phase 3Taking people
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Where
Dresden
Age
18 years to 65 years
People
57 worldwide
Run by
Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Deggingen, Essen, Gelnhausen, Hamburg, Hohenmölsen, Jerichow, Leipzig, Ratingen
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
No phaseTaking people
INNODIA Family & Friends Early-Stage T1D Detection Protocol
Where
Greifswald
Age
1 year to 45 years
People
30,000 worldwide
Run by
INNODIA iVZW
See details and how to joinNCT07118098
Phase 4Taking people
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
Where
Amberg, Bad Mergentheim, Bad Reichenhall, Berlin, Bünde, Daaden, Dortmund, Dresden, Duisburg, Eisenach, Essen, Fulda, Hamburg, Hof, Jerichow, Leipzig, Lichtenfels, Ludwigsburg, Osnabrück, Pohlheim, Singen (Hohentwiel), Trier
Age
18 years and over
People
586 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07112339 · EU 2024-520068-32-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Where
Amberg, Bad Oeynhausen, Berlin, Duisburg, Eisenach, Elsterwerda, Falkensee, Frankfurt am Main, Gladbeck, Hamburg, Magdeburg, Mannheim, Münster, Nittendorf, Obertshausen, Oldenburg in Holstein, Pirna
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00
Phase 1Taking people
A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes
Where
Neuss
Age
18 years to 64 years
People
60
Run by
Novo Nordisk A/S
See details and how to joinNCT07270731 · EU 2024-519382-22-00
Phase 1Taking people
A Double-blind, Placebo-controlled, Multiple-Dose, 2-Period Crossover Study to Evaluate the Effect of Steady-state AZD6793 on the Steady-state Pharmacokinetics/Pharmacodynamics of Metformin in Participants with Type 2 Diabetes Mellitus
Where
Neuss
Age
18 years and over
People
35
Run by
AstraZeneca AB
See details and how to join2025-522551-25-00 · EU 2025-522551-25-00
Phase 1Taking people
Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes
Where
Neuss
Age
18 years to 75 years
People
80
Run by
Novo Nordisk A/S
See details and how to joinNCT07535307 · EU 2025-521595-55-00
Phase 2Taking people
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia
Where
Duesseldorf
Age
18 years to 75 years
People
300 worldwide
Run by
Marc Donath
See details and how to joinNCT06047262 · EU 2024-511828-14-00
No phaseTaking people
Disentangling the Effect of Brain Insulin Resistance on Brain Health
Where
Ulm
Age
50 years to 80 years
People
150 worldwide
Run by
Henrik Bo Wiberg Larsson
See details and how to joinNCT07374705
No phaseTaking people
Mitochondrial Substrate Utilization in the Diabetic Human Heart
Where
Düsseldorf
Age
20 years to 85 years
People
500
Run by
Heinrich-Heine University, Duesseldorf
See details and how to joinNCT05958706
No phaseNot yet taking people in Germany
Multicentric Approval Study Trans-Duodenal Barrier for Typ 2 Diabetes With Obesity
Where
Bamberg, Berlin, Bochum, Dresden, Leipzig, Mannheim, Würzburg
Age
18 years and over
People
126
Run by
Trans-Duodenal Concepts GmbH
See details and how to joinNCT07417683
No phaseTaking people
Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
Where
Düsseldorf
Age
18 years and over
People
200
Run by
Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06124586